Cetera Investment Advisers
ACAD icon

Cetera Investment Advisers’s Acadia Pharmaceuticals ACAD Stock Holding History

Cetera Investment Advisers’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$606K Buy
23,958
+4,760
+25% +$105K ﹤0.01% 3518
2026
Q1 		$427K Buy
19,198
+2,843
+17% +$67.9K ﹤0.01% 3655
2025
Q4 		$437K Buy
16,355
+436
+3% +$10.4K ﹤0.01% 3552
2025
Q3 		$340K Buy
15,919
+3,156
+25% +$74.6K ﹤0.01% 3732
2025
Q2 		$275K Buy
12,763
+931
+8% +$17.3K ﹤0.01% 3470
2025
Q1 		$197K Buy
+11,832
New +$215K ﹤0.01% 3614
2024
Q2 		– Sell
-11,559
Closed -$214K – 3726
2024
Q1 		$214K Buy
+11,559
New +$286K ﹤0.01% 3309

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Cetera Investment Advisers's ACAD Position: Q2 2026 in Review

Cetera Investment Advisers increased its Acadia Pharmaceuticals (ACAD) stake by 25% in Q2 2026, buying an estimated $105K and bringing the position to 23,958 shares worth $606K. The position accounts for ﹤0.01% of the portfolio, ranked #3518.

Cetera Investment Advisers first reported a position in ACAD in Q1 2024 and has held it in 7 quarters since. 353 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Cetera Investment Advisers held 23,958 shares of Acadia Pharmaceuticals worth $606K as of Q2 2026.
  • Cetera Investment Advisers bought 4,760 Acadia Pharmaceuticals shares in Q2 2026, an estimated $105K.
  • Acadia Pharmaceuticals made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3518 holding.
  • Cetera Investment Advisers first reported a position in Acadia Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
  • 353 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.